Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases
Chuang-Yu Lin, Michiko Yoshida, Li-Tzu Li, Akihiro Ikenaka, Shiori Oshima, Kazuhiro Nakagawa, Hidetoshi Sakurai, Eriko Matsui, Tatsutoshi Nakahata, Megumu K. Saito
Chuang-Yu Lin, Michiko Yoshida, Li-Tzu Li, Akihiro Ikenaka, Shiori Oshima, Kazuhiro Nakagawa, Hidetoshi Sakurai, Eriko Matsui, Tatsutoshi Nakahata, Megumu K. Saito
View: Text | PDF
Research Article Neuroscience Stem cells

iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases

  • Text
  • PDF
Abstract

The control of voluntary skeletal muscle contraction relies on action potentials, which send signals from the motor neuron through the neuromuscular junction (NMJ). Although dysfunction of the NMJ causes various neuromuscular diseases, a reliable in vitro system for disease modeling is currently unavailable. Here, we present a potentially novel 2-step, self-organizing approach for generating in vitro human NMJs from human induced pluripotent stem cells. Our simple and robust approach results in a complex NMJ structure that includes functional connectivity, recapitulating in vivo synapse formation. We used these in vitro NMJs to model the pathological features of spinal muscular atrophy, revealing the developmental and functional defects of NMJ formation and NMJ-dependent muscular contraction. Our differentiation system is therefore useful for investigating and understanding the physiology and pathology of human NMJs.

Authors

Chuang-Yu Lin, Michiko Yoshida, Li-Tzu Li, Akihiro Ikenaka, Shiori Oshima, Kazuhiro Nakagawa, Hidetoshi Sakurai, Eriko Matsui, Tatsutoshi Nakahata, Megumu K. Saito

×

Figure 4

Fine structures of hNMJs and developmental stage analysis.

Options: View larger image (or click on image) Download as PowerPoint
Fine structures of hNMJs and developmental stage analysis.
(A) Scanning ...
(A) Scanning electron microscopy images show swelling axon terminals binding to a myotube. (B) TEM images show a synaptic bouton capped by the terminal Schwann cell and myelinated axon. (C) The TEM image shows synaptic vesicles (arrowheads) in presynaptic sites, active zones (arrows), and mitochondria accumulated in postsynaptic sites. (D) Enlarged axon terminals observed inside a myotube. Junctional folds are seen as electron-dense areas. (E) A neuron innervating a myotube (m) and an electron-dense area observed on the muscle plasma membrane. (F) Multiply branched axon terminals observed in a myotube. Electron-dense areas (arrows) locate at each axon terminal. Mitochondria (mt) are found nearby. (G) Necrosis was observed among the axon terminals (arrows). (H) An active zone (arrowhead) juxtaposed to the postsynaptic density (PSD, arrow) with a synaptic cleft observed in between. (I) Synaptic vesicles (SV) docked to the active zone (arrows). (J) A subneural cleft surrounded by sarcolemma with AChRs residing inside. (K) NMJ frequencies with agrin and antiagrin treatment in NMJ cultures at day 30. See also Supplemental Figure 8. (L) Change in NMJ morphology with agrin or antiagrin antibody treatment. Scale bars: 1 μm (A–D), 100 nm (E–J and L). (K) *P < 0.05; **P < 0.01 (1-way ANOVA with Tukey’s test relative to untreated control). Data are shown as mean ± SEM; n = 6 (agrin and antiagrin); n = 5 (untreated control). Each dot represents a biologically independent sample.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts